Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Roti

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
European Journal of Medicinal Chemistry|July 18, 2024
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell lineLorenzo Guidetti, Riccardo Castelli, Alfonso Zappia, et al.
Vascular Pharmacology|September 14, 2022
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitroBruno Lorusso, Giuseppe Cerasoli, Angela Falco, et al.
Lung Cancer (Amsterdam, Netherlands)|May 4, 2020
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLCGiulia Mazzaschi, Gianluca Milanese, Paolo Pagano, et al.
Data in Brief|June 18, 2020
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung CancerGiulia Mazzaschi, Gianluca Milanese, Paolo Pagano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic LeukemiaYana Pikman, Gabriela Alexe, Giovanni Roti, et al.
Leukemia|May 6, 2020
Activating somatic and germline TERT promoter variants in myeloid malignanciesValeria Nofrini, Caterina Matteucci, Fabrizia Pellanera, et al.
Journal of Thoracic Imaging|August 27, 2024
Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint InhibitorsMaurizio Balbi, Giulia Mazzaschi, Ludovica Leo, et al.
Tumori|March 18, 2021
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patientsFrancesca Trentini, Giulia Mazzaschi, Gianluca Milanese, et al.
International Journal of Cancer|March 7, 2018
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemiaStefano Baldoni, Beatrice Del Papa, Erica Dorillo, et al.
Leukemia|August 3, 2021
Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapyYana Pikman, Nicole Ocasio-Martinez, Gabriela Alexe, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Medicinal Chemistry|July 18, 2024
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell lineLorenzo Guidetti, Riccardo Castelli, Alfonso Zappia, et al.
Vascular Pharmacology|September 14, 2022
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitroBruno Lorusso, Giuseppe Cerasoli, Angela Falco, et al.
Lung Cancer (Amsterdam, Netherlands)|May 4, 2020
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLCGiulia Mazzaschi, Gianluca Milanese, Paolo Pagano, et al.
Data in Brief|June 18, 2020
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung CancerGiulia Mazzaschi, Gianluca Milanese, Paolo Pagano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic LeukemiaYana Pikman, Gabriela Alexe, Giovanni Roti, et al.
Leukemia|May 6, 2020
Activating somatic and germline TERT promoter variants in myeloid malignanciesValeria Nofrini, Caterina Matteucci, Fabrizia Pellanera, et al.
Journal of Thoracic Imaging|August 27, 2024
Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint InhibitorsMaurizio Balbi, Giulia Mazzaschi, Ludovica Leo, et al.
Tumori|March 18, 2021
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patientsFrancesca Trentini, Giulia Mazzaschi, Gianluca Milanese, et al.
International Journal of Cancer|March 7, 2018
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemiaStefano Baldoni, Beatrice Del Papa, Erica Dorillo, et al.
Leukemia|August 3, 2021
Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapyYana Pikman, Nicole Ocasio-Martinez, Gabriela Alexe, et al.
Pageof 8